Board Meeting30 Oct 2026, 06:12 pm
Genomic Valley Biotech Ltd Board Approves Un-Audited Financial Results
AI Summary
Genomic Valley Biotech Ltd announced the outcome of its Board Meeting held on October 30, 2026. The Board of Directors considered and approved the standalone un-audited financial results for the quarter and half-year ended September 30, 2026. A limited review report from the statutory auditor was also enclosed. The meeting commenced at 05:15 PM and concluded at 05:45 PM.
Key Highlights
- Board meeting held on October 30, 2026.
- Approved standalone un-audited financial results.
- Results for the quarter and half-year ended September 30, 2026.
- Limited review report from statutory auditor enclosed.
Price Impact
More from GVBL